Direct Energy Devices Market - Forecast(2024 - 2030)

Direct Energy Devices Market Overview

Direct Energy Devices Market size is estimated to reach $1.9 billion by 2027, growing at a CAGR of 4.4% during the forecast period 2022-2027. Direct energy devices are widely used in the medical sector to execute minimally invasive surgeries (MIS), a captivating substitute for traditional methods of curing diseases. These devices run upon components like ultrasonic energy, bipolar, and many more. Laparoscopic hysterectomy is one of the most significant surgical procedures executed with the help of energy devices like thunder beat and harmonic scalpel. Moreover, various ultrasonic dissection devices are taken into account while performing pancreatic surgery. several other instruments like elctrotome, cryoprobe have come to the foreground in recent years as procedures like electrosurgery and cryotherapy are prevailing. The Discovery of such devices is the best thing since sliced bread as they extend several benefits to patients as well as doctors performing the surgeries. They offer lower recovery time and distress to a patient during and after the surgeries. In addition to that, they help doctors in performing complex procedures with utmost ease like dissecting the soft tissue. The growing prevalence of cancer and other cardiovascular hitches, proliferating beauty treatments are factors set to drive the growth of the Direct Energy Devices Market for the period 2022-2027.

Report Coverage

The report: “Direct Energy Devices Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Direct Energy Devices Market.

By Application: Ophthalmology, cardiovascular, Aesthetics, Orthopaedics, Gynaecology, and others.
By Type: Electrical, Thermal, Radiation, Light, Radiofrequency, Hydromechanical, and others.
By End User: Hospitals, diagnostics Centres, Research Centres, and others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (the Middle East and Africa).

Key Takeaways

• Geographically, the North America Direct Energy Devices Market accounted for the highest revenue share in 2021. However, Asia-Pacific is poised to dominate the market over the period 2022-2027.
• Accruing cardiovascular complications are said to be a pre-eminent driver steering the growth of the Direct Energy Devices Market. Setbacks experienced by the respective industry due to COVID-19 and the high cost of such procedure as compared to traditional therapies are said to reduce the market growth.
• Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Direct Energy Devices Market report.

Direct Energy Devices Market Segment Analysis-By Application

The Direct Energy Devices Market based on the application type can be further segmented into Ophthalmology, cardiovascular, Aesthetics, Orthopaedics, Gynaecology, and others. The orthopedics segment held the largest share in 2021. The growth is owing to proliferating prevalence of musculoskeletal complications like loss of connective tissue cartilage which leads to arthritis, other spine and ligament irregularities. These problems heightened with age therefore accruing the old-age population around the world is leading to significant growth in this segment. A report claimed that there are over 350 million patients globally suffering from joint abnormalities. In addition to that, elevating sporting injuries are another big factor for growth in the respective segment. However, the aesthetics segment is estimated to be the fastest-growing segment with a CAGR of 5.1% over the forecast period 2022-2027. This growth is owing to augmenting obsession among people regarding their looks expanding the demand for cosmetics surgeries. Plastic surgeries, facial hair removals, lip fillers, and other anti-aging procedures are being widely used nowadays.

Direct Energy Devices Market Segment Analysis-By Type

The Direct Energy Devices Market based on type can be further segmented into Electrical, Thermal, Radiation, Light, Radiofrequency, Hydromechanical, and others. The radiofrequency segment held the largest share in 2021. The growth is owing to widespread use in aesthetic surgeries. Obesity is a major health hurdle that has come to the foreground on an unprecedented scale in recent years. Around 36.20% of adults in the US are suffering from overweight problems in 2021. The number is further expected to broaden in the upcoming future. Therefore, surgical procedures like lipolysis are being used on a wider scale to cut the size of fatty tissue by breaking down the lipids with the help of a laser. Radiofrequency energy is an indispensable part of imaging techniques like magnetic resonance imaging (MRI) and helps in producing precise and clear images. The light and the electrical segment is estimated to be the fastest-growing segment with a CAGR of 5.2% over the forecast period 2022-2027. This growth is owing to piling applications in making enormously fine incisions in sensitive areas where traditional tools like knives can’t be used. In addition to that, these devices also find their place in cosmetic procedures to condense the scars.

Direct Energy Devices Market Segment Analysis-By Geography

The Direct Energy Devices Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held the largest share with 39% of the overall market in 2021. The growth in this segment is owing to the factors such as top-notch healthcare infrastructure in the US and Canada attribution to affluent economies. Moreover, high health consciousness among people and fine purchasing power encourage them to go for cosmetic procedures. On another hand, widespread obesity in the US is another big reason fueling the growth in the respective segment. By 2025 around 60-64% of the population in the US is anticipated to turn obese. However, the Asia-Pacific segment is expected to be the fastest-growing segment over the forecast period 2022-2027. This growth is owing to elevating population in Asian countries. Furthermore, the prevalence of cancer and other cardiovascular diseases has been heightened in recent years. Besides, prospering economies of Asian nations encouraging the government to spend more upon healthcare infrastructure, research, and development are driving the growth.

Direct Energy Devices Market Drivers

Augmenting prevalence of cancer and arthritis is Anticipated to Boost Product Demand

As cancer cases are shooting up worldwide, the use of direct energy devices in surgeries is also expanding. More than 1.9 million cases of cancer were diagnosed in the US and Over 600,000 deaths were reported in 2021. In addition to that, according to a report by International Agency for Research on Cancer (IARC), the global cancer is cases are anticipated to spike by 27 million by the year 2040. On another hand, arthritis complication is surging owing to expansion in the old-age population. There are more than 340-350 million cases of joint abnormalities as of 2021 and anticipated to surge in foreseeable future.

Growing cosmetic procedures with accruing population are Expected to Boost Product Demand

The faction of the entire population that is aging above 60 years as of 2021 stands around 600-700 million but the number is estimated to witness a hike and reach 1-2 billion in upcoming years. Therefore, with the growing geriatric population, the trend of cosmetic procedures has been elevated enormously. People are undergoing liposuction (plastic surgery), lip filling procedures, and skin tightening to look young. A report suggests that around 15 million aesthetic surgeries are performed every year in the US. Out of which around 12-13 million are executed through minimally invasive procedures.

Direct Energy Devices Market Challenges

The reduced purchasing power of people and frozen health procedures due to COVID-19 are Anticipated to Hamper Market Growth

Even though the direct energy devices market is evergreen considering the speed at which diseases are prevailing but the COVID-19 outbreak can hamper its growth. The governments around the globe are reconsidering imposing lockdowns in the wake of heightening cases and virus mutations which disrupt the workflow and supply chain of hospitals and other medical facilities through a reduced workforce. On another hand, a reduction in peoples’ purchasing capacity may turn them unwilling to undergo expensive aesthetic procedures.

Direct Energy Devices Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in this market. Direct Energy Devices top 10 companies include:

1. Medtronic
2. Boston Scientific Corporation
3. Ethicon, In
4. Olympus Corporation
5. CONMED Corporation
6. Karl Storz
7. B. Braun Mels0ungen AG
8. Aesthera
9. Sciton
10. Palomar Medical

Recent Developments

• October 6, 2021, Boston Scientific Corporation publicized that it has signed an agreement to acquire Canada-based medical device manufacturing company “Baylis Medical.” In the agreement, Boston Agreed to pay $1.75 billion to Baylis. Moreover, this acquisition will be going to help Boston in expanding its portfolio in heart products.
• September 1, 2021, US-based medical device manufacturer Boston Scientific announced that it has successfully acquired the surgical business of Israel-based company “Lumenis Ltd.” which is famous for its minimally invasive clinical solutions. The agreement was brought to a close with a payment of $1.07 billion. Moreover, the step allows Boston Scientific access to the laser business of Lumenis.
• August 6, 2021, Ireland-based medical device company “Medtronic” publicized that it has signed an agreement to acquire all outstanding shares of US-based medical technology firm “Intersect ENT”. Agreement was reached after Medtronic agree to pay $1.1 billion to Intersect. Existing shareholders will be paid $28.25 per share on completion of the process.

Relevant Links:

Cancer Hormone Therapy Market – Forecast (2021 - 2026)
Report Code: HCR 0196

Cancer Biomarkers Market-Forecast (2021-2026)
Report Code: HCR 0194

For more Lifesciences and Healthcare Market reports, please click here